Cogentix Medical: Your partner in care of faecal incontinence

cogentix-faecal-incontinence-1.jpgProducts for PTNS neuromodulation and bulking of internal anal sphincter 

With approximately 11-15% of the elderly population affected by faecal incontinence, it is a condition affecting many lives.1 Faecal incontinence has an impact on virtually all aspects of peoples' lives, greatly diminishing physical and mental health, and affecting personal, social and professional life. Patients with faecal incontinence often also suffer from urinary incontinence. It has been shown that up to 30% of women suffering from urinary incontinence also suffer from faecal incontinence.1

Cogentix Medical offers minimally-invasive products to treat Faecal Incontinence as part of the continuum of care after drugs and behavourial treatments have failed. Faecal incontinence solutions include the following:

cogentix-reimbursement-urgent-pc.pngOut-patient Neuromodulation

Urgent® PC is out-patient percutaneous tibial nerve stimulation (PTNS) and falls under the NICE interventional procedure guidance IPG395. 


PTQ_SingleVial0209.jpgBulking of Internal Anal Sphincter

PTQ® is an injectable bulking agent used for trans-sphincteric implantation in the Internal Anal Sphincter. The procedure is minimally-invasive and can be done under local anaesthesia in an outpatient or day case procedure. 


1 Milson, I., Altman, D., Cartwrights, R., Lapitan, M.C., Neslon, R., Sillen, U. & Tikkinen. (2013). Epidemiology of urinary uncontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal incontinence (AI). In Abrams, P., Cardozo, L., Khoury, S. & Wein, A.( Ed.) Incontinence. (pp. 17 – 103). ICUD-EAU.